EIPICO has not determined the financing method of the project, however, it received many bank proposals for financing which are under examination.
The company posted a consolidated net profit of EGP 262.201 million in the first half (H1) of 2020, a 34% decrease from EGP 398.350 million achieved in H1 2019.
EIPICO is an Egypt-based public shareholding company that operates in the pharmaceutical industry. It is a manufacturer and exporter of pharmaceuticals and holds license agreements with a group of international pharmaceutical companies to produce their products locally and replace the imported ones.
Copyright © 2020 Arab Finance Brokerage Company All rights reserved. Provided by SyndiGate Media Inc. (Syndigate.info).